These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18601602)

  • 1. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain.
    Garcés C; López-Simón L; Rubio R; Benavente M; Cano B; Ortega H; de Oya M
    Clin Chem Lab Med; 2008; 46(6):809-13. PubMed ID: 18601602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
    Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
    J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of paraoxonase gene polymorphisms with sperm parameters.
    Lazaros LA; Xita NV; Hatzi EG; Kaponis AI; Stefos TJ; Plachouras NI; Makrydimas GV; Sofikitis NV; Zikopoulos KA; Georgiou IA
    J Androl; 2011; 32(4):394-401. PubMed ID: 21127310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
    Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
    Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
    Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy.
    Pérez-Herrera N; May-Pech C; Hernández-Ochoa I; Castro-Mañé J; Rojas-García E; Borja-Aburto VH; Castillo-Burguete T; Quintanilla-Vega B
    Exp Mol Pathol; 2008 Oct; 85(2):129-34. PubMed ID: 18582459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
    Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
    Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
    Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.
    de Souza JA; Menin A; Lima LO; Smiderle L; Hutz MH; Van Der Sand CR; Van Der Sand LC; Ferreira ME; Pires RC; Almeida S; Fiegenbaum M
    Clin Biochem; 2015 Nov; 48(16-17):1039-44. PubMed ID: 26079344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 1 status in the Thai population.
    Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
    J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
    Inoue M; Suehiro T; Nakamura T; Ikeda Y; Kumon Y; Hashimoto K
    Metabolism; 2000 Nov; 49(11):1400-5. PubMed ID: 11092501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
    Ferré N; Feliu A; García-Heredia A; Marsillach J; París N; Zaragoza-Jordana M; Mackness B; Mackness M; Escribano J; Closa-Monasterolo R; Joven J; Camps J
    Clin Biochem; 2013 Dec; 46(18):1830-6. PubMed ID: 24028901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
    Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
    Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
    Sentí M; Tomás M; Marrugat J; Elosua R;
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
    AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
    Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.